SBFMW Financials: Sunshine Biopharma, Inc. AI Analysis

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	129,079	129,079	133,125	134,598	123,675	124,493
Revenue Growth (YoY)	-3%	-3%	-1%	9%	-1%	16%
Cost of Revenue	72,436	72,436	66,102	65,031	56,134	54,208
Gross Profit	56,643	56,643	67,023	69,567	67,541	70,285
Selling, General & Admin	25,843	25,843	23,620	23,519	20,514	24,723
Research & Development	20,433	20,433	22,133	24,192	23,315	24,938
Operating Expenses	46,276	46,276	45,753	47,711	51,629	59,761
Other Non Operating Income (Expenses)	5,767	5,767	2,193	2,402	-6,637	162
Pretax Income	6,716	6,716	28,622	25,198	10,112	10,778
Income Tax Expense	1,259	1,259	4,447	3,649	2,578	3,187
Net Income	5,589	5,589	23,172	19,598	6,968	9,876
Net Income Growth	-76%	-76%	18%	181%	-28.99%	-56%
Shares Outstanding (Diluted)	2,758	2,744	2,798	2,837	2,809	2,814
Shares Change (YoY)	-1%	-2%	-1%	1%	0%	2%
EPS (Diluted)	2.02	2.04	8.28	6.91	2.48	3.51
EPS Growth	-76%	-75%	20%	179%	-28.99%	-56.99%
Free Cash Flow	--	--	12,975	25,320	17,777	8,882
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	43.88%	43.88%	50.34%	51.68%	54.61%	56.45%
Operating Margin	8.03%	8.03%	15.97%	16.23%	12.86%	8.45%
Profit Margin	4.32%	4.32%	17.4%	14.56%	5.63%	7.93%
Free Cash Flow Margin	--	--	9.74%	18.81%	14.37%	7.13%
EBITDA	--	--	41,791	43,313	23,712	20,624
EBITDA Margin	--	--	31.39%	32.17%	19.17%	16.56%
D&A For EBITDA	--	--	20,521	21,457	7,800	10,100
EBIT	10,367	10,367	21,270	21,856	15,912	10,524
EBIT Margin	8.03%	8.03%	15.97%	16.23%	12.86%	8.45%
Effective Tax Rate	18.74%	18.74%	15.53%	14.48%	25.49%	29.56%

Sunshine Biopharma, Inc. (SBFMW) Financial